» Authors » K-P Kim

K-P Kim

Explore the profile of K-P Kim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 165
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jun S, An S, Hong S, Kim J, Kim K
ESMO Open . 2024 Nov; 9(11):103969. PMID: 39510021
Background: The assessment of tumor-infiltrating lymphocytes (TILs) has led to the development of various immunotherapies beyond their predictive potential in gastrointestinal malignancies. However, the clinicopathologic and prognostic values of TILs...
2.
Jeong H, Shin J, Jeong J, Kim K, Hong S, Kim Y, et al.
ESMO Open . 2021 Apr; 6(3):100119. PMID: 33901869
Background: Grade 3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) origin with Ki-67 indices <55% do not respond well to platinum-based chemotherapy. The combination of capecitabine and temozolomide (CAPTEM) has shown...
3.
Bolch W, Eckerman K, Endo A, Hunt J, Jokisch D, Kim C, et al.
Ann ICRP . 2020 Oct; 49(1):5-297. PMID: 33000625
No abstract available.
4.
Kim J, Shin J, Moon J, Hong S, Jung D, Kim J, et al.
Oncogene . 2016 May; 36(2):219-230. PMID: 27238838
The downstream events and target genes of p53 in the process of senescence are not fully understood. Here, we report a novel function of the forkhead transcription factor Foxp3, which...
5.
Hong S, Moon J, Kim J, Shin J, Jung K, Lee W, et al.
Cell Death Differ . 2013 Oct; 21(1):146-60. PMID: 24141722
PTEN is one of the most frequently mutated or deleted tumor suppressors in human cancers. NEDD4-1 was recently identified as the E3 ubiquitin ligase for PTEN; however, a number of...
6.
Park M, Shin K, Kim K, Kim T, Yoon S, Cho J, et al.
Int J Clin Pharmacol Ther . 2011 Oct; 49(11):672-8. PMID: 22011692
Background: Sertraline is a naphthalenamine derivative which has the effect of selective serotonin reuptake inhibition. It has been used for major depression, and obsessive compulsive disorder. This study was performed...
7.
Kim S, Lee S, Hong M, Song N, Yoon B, Viet P, et al.
J Microbiol Biotechnol . 2011 Jul; 21(7):679-85. PMID: 21791953
Xanthomonas oryzae pv. oryzae (Xoo) produces a putative effector, XoAvrBs2. We expressed XoAvrBs2 homologously in Xoo with a TAP-tag at the C-terminus to enable quantitative analysis of protein expression and...
8.
Park S, Kim J, Yoon H, Lee I, Yoon H, Kim K
Clin Radiol . 2011 Mar; 66(4):322-8. PMID: 21356394
Aim: To evaluate the clinical outcome and the survival benefits of transarterial chemoembolization (TACE) for unresectable intrahepatic cholangiocarcinoma (ICC) compared with supportive therapy. Materials And Methods: From January 1996 to...
9.
Kim K, Jang G, Hong Y, Lim H, Bae K, Kim H, et al.
Br J Cancer . 2011 Feb; 104(4):605-12. PMID: 21326246
Background: Advanced biliary cancer is often treated with fluoropyrimidine-based chemotherapy. In this study, we evaluated the efficacy and tolerability of a combination of S-1, an oral fluoropyrimidine prodrug, and oxaliplatin...